Featured Research

from universities, journals, and other organizations

Advantages of minimally invasive surgery to treat hyperparathyroidism

Date:
October 16, 2013
Source:
American Thyroid Association
Summary:
The results of a study designed to compare cure rates, postoperative pain, cosmetic satisfaction, and length of the procedure and of the hospital stay for patients with hyperparathyroidism who underwent BNE versus minimally invasive video-assisted (MIVAP) parathyroidectomy have been released.

An open surgical procedure called bilateral neck exploration (BNE) has been the gold standard operation for treating patients with primary hyperparathyroidism. But the development of a minimally invasive procedure to remove the parathyroid gland now offers a new option. A study designed to compare cure rates, postoperative pain, cosmetic satisfaction, and length of the procedure and of the hospital stay for patients with hyperparathyroidism who underwent BNE versus minimally invasive video-assisted (MIVAP) parathyroidectomy will be presented in a poster at the 83rd Annual Meeting of the American Thyroid Association, October 16-20, 2013, in San Juan, Puerto Rico.

Youben Fan, from Affiliated Sixth People's Hospital, Shanghai, China, reports no difference in cure rates between the two approaches, or in the frequency with which treated patients have persistent or recurrent hyperparathyroidism. MIVAP demonstrated several advantages compared to BNE, including a lower incidence of early severe hypocalcemia, a higher cosmetic satisfaction rate, shorter operations, less postoperative pain, and shorter hospital stays. These findings are presented in the poster entitled "Minimally Invasive Video-assisted Parathyroidectomy Compared with the Conventional Open Operation for Primary Hyperparathyroidism: A Randomized Controlled Trial."

"Primary hyperparathyroidism is a common condition for which parathyroidectomy is curative," says Julie Ann Sosa, MD, Program Committee Co-Chair; Professor of Surgery and Medicine, Chief, Section of Endocrine Surgery, and Director of Health Services Research, Department of Surgery, Duke University School of Medicine; and Leader, Endocrine Neoplasia Diseases Group, Duke Cancer Institute and Duke Clinical Research Institute, Durham, NC.

"While bilateral neck exploration has been the traditional approach, minimally invasive parathyroidectomy has emerged as an alternative technique associated with improved patient outcomes, largely based on retrospective, single institution or surgeon clinical series. This report is potentially exciting because it represents a randomized controlled trial and specifically looks at minimally invasive, video-assisted parathyroidectomy as compared to traditional open parathyroidectomy.


Story Source:

The above story is based on materials provided by American Thyroid Association. Note: Materials may be edited for content and length.


Cite This Page:

American Thyroid Association. "Advantages of minimally invasive surgery to treat hyperparathyroidism." ScienceDaily. ScienceDaily, 16 October 2013. <www.sciencedaily.com/releases/2013/10/131016095841.htm>.
American Thyroid Association. (2013, October 16). Advantages of minimally invasive surgery to treat hyperparathyroidism. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/10/131016095841.htm
American Thyroid Association. "Advantages of minimally invasive surgery to treat hyperparathyroidism." ScienceDaily. www.sciencedaily.com/releases/2013/10/131016095841.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins